Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Magellan Health Inc (MGLN)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Magellan Health Inc.
Table 2 shows the detailed insider transactions.
This company's CIK number is 19411.
Total stock buying since 2014: $1,495,043.
Total stock sales since 2014: $97,125,412.
Total stock option exercises since 2014: $0.
Table 3. Detailed insider trading at Magellan Health Inc (MGLN)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2022-01-02 | Murray James E (President and COO) | Option Ex | 3,262 | .00 | 0 |
2021-12-02 | Fasola Kenneth J (Chief Executive Officer) | Option Ex | 8,580 | .00 | 0 |
2021-10-01 | Bourdon David (Chief Financial Officer) | Option Ex | 2,192 | .00 | 0 |
2021-03-05 | West Jeffrey N (SVP & Controller) | Option Ex | 2,286 | .00 | 0 |
2021-03-04 | Kamal Mostafa (CEO, Magellan Rx Management) | Option Ex | 6,242 | .00 | 0 |
2021-03-04 | Lewis Clapper Caskie (Chief Human Resources Officer) | Option Ex | 2,435 | .00 | 0 |
2021-03-04 | West Jeffrey N (SVP & Controller) | Option Ex | 1,769 | .00 | 0 |
2021-03-04 | Fasola Kenneth J (Chief Executive Officer) | Option Ex | 11,099 | .00 | 0 |
2021-03-04 | Murray James E (President and COO) | Option Ex | 7,284 | .00 | 0 |
2021-03-02 | Haddock David (General Counsel & Secretary) | Option Ex | 4,237 | .00 | 0 |
2021-01-02 | Murray James E (President and COO) | Option Ex | 3,262 | .00 | 0 |
2020-12-09 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 2,793 | 79.69 | 222,574 |
2020-12-02 | Fasola Kenneth J (Chief Executive Officer) | Option Ex | 8,580 | .00 | 0 |
2020-11-16 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 7,603 | 86.57 | 658,191 |
2020-11-13 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 13,282 | 83.82 | 1,113,323 |
2020-11-10 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 6,000 | 81.57 | 489,419 |
2020-11-05 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 3,589 | 79.87 | 286,653 |
2020-11-04 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 3,434 | 79.89 | 274,352 |
2020-11-04 | West Jeffrey N (SVP & Controller) | Sale | 2,620 | 80.00 | 209,602 |
2020-10-16 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 183 | 79.87 | 14,616 |
2020-10-07 | West Jeffrey N (SVP & Controller) | Sale | 1,500 | 78.50 | 117,753 |
2020-10-06 | West Jeffrey N (SVP & Controller) | Sale | 4,778 | 78.50 | 375,092 |
2020-10-05 | West Jeffrey N (SVP & Controller) | Sale | 14,637 | 78.51 | 1,149,106 |
2020-06-08 | West Jeffrey N (SVP & Controller) | Sale | 1,415 | 78.50 | 111,077 |
2020-05-15 | Murray James E (President and COO) | Buy | 4,500 | 67.63 | 304,317 |
2020-03-05 | West Jeffrey N (SVP & Controller) | Option Ex | 2,287 | .00 | 0 |
2020-03-03 | Kamal Mostafa (CEO, Magellan Rx Management) | Option Ex | 4,365 | .00 | 0 |
2020-03-03 | Rubin Jonathan N (Chief Financial Officer) | Option Ex | 5,675 | .00 | 0 |
2020-03-03 | Lewis Clapper Caskie (Chief Human Resources Officer) | Option Ex | 2,837 | .00 | 0 |
2020-03-03 | West Jeffrey N (SVP & Controller) | Option Ex | 1,844 | .00 | 0 |
2020-01-02 | West Jeffrey N (SVP & Controller) | Sale | 200 | 78.53 | 15,706 |
2019-12-30 | West Jeffrey N (SVP & Controller) | Sale | 104 | 78.50 | 8,164 |
2019-12-27 | West Jeffrey N (SVP & Controller) | Sale | 606 | 78.54 | 47,597 |
2019-12-26 | West Jeffrey N (SVP & Controller) | Sale | 1,923 | 78.52 | 150,986 |
2019-12-24 | West Jeffrey N (SVP & Controller) | Sale | 6,114 | 78.54 | 480,169 |
2019-12-16 | West Jeffrey N (SVP & Controller) | Sale | 5,735 | 78.62 | 450,885 |
2019-12-09 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 16,766 | 78.72 | 1,319,735 |
2019-03-05 | West Jeffrey N (SVP & Controller) | Option Ex | 839 | .00 | 0 |
2019-03-03 | Kamal Mostafa (CEO, Magellan Rx Management) | Option Ex | 3,996 | .00 | 0 |
2019-03-03 | Rubin Jonathan N (Chief Financial Officer) | Option Ex | 5,195 | .00 | 0 |
2019-03-03 | Lewis Clapper Caskie (Chief Human Resources Officer) | Option Ex | 2,248 | .00 | 0 |
2019-03-03 | West Jeffrey N (SVP & Controller) | Option Ex | 2,940 | .00 | 0 |
2019-03-03 | Smith Barry M (Chief Executive Officer) | Option Ex | 19,980 | .00 | 0 |
2019-03-03 | Gregoire Daniel N (General Counsel and Secretary) | Option Ex | 2,757 | .00 | 0 |
2018-11-02 | Rubin Jonathan N (Chief Financial Officer) | Option Ex | 2,420 | .00 | 0 |
2018-07-02 | Smith Barry M (Chief Executive Officer) | Sale | 13,375 | 95.86 | 1,282,060 |
2018-06-01 | Smith Barry M (Chief Executive Officer) | Sale | 13,375 | 92.21 | 1,233,322 |
2018-05-01 | Smith Barry M (Chief Executive Officer) | Sale | 13,375 | 86.02 | 1,150,571 |
2018-04-02 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 1,666 | 106.20 | 176,929 |
2018-04-02 | Smith Barry M (Chief Executive Officer) | Sale | 13,375 | 103.52 | 1,384,580 |
2018-03-07 | Kamal Mostafa (CEO, Magellan Rx Management) | Option Ex | 727 | .00 | 0 |
2018-03-07 | Srivastava Sanjeev K (CEO, Magellan Healthcare) | Option Ex | 7,577 | .00 | 0 |
2018-03-07 | Lewis Clapper Caskie (Chief Human Resources Officer) | Option Ex | 3,367 | .00 | 0 |
2018-03-07 | West Jeffrey N (SVP & Controller) | Option Ex | 2,556 | .00 | 0 |
2018-03-07 | Smith Barry M (Chief Executive Officer) | Option Ex | 23,000 | .00 | 0 |
2018-03-07 | Gregoire Daniel N (General Counsel and Secretary) | Option Ex | 4,107 | .00 | 0 |
2018-03-05 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 15,428 | 99.04 | 1,527,973 |
2018-03-05 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 22,875 | 99.05 | 2,265,700 |
2018-03-04 | Kamal Mostafa (CEO, Magellan Rx Management) | Option Ex | 175 | .00 | 0 |
2018-03-04 | West Jeffrey N (SVP & Controller) | Option Ex | 615 | .00 | 0 |
2018-03-03 | West Jeffrey N (SVP & Controller) | Option Ex | 2,087 | .00 | 0 |
2018-03-02 | Smith Barry M (Chief Executive Officer) | Option Ex | 2,534 | .00 | 0 |
2018-03-01 | Smith Barry M (Chief Executive Officer) | Sale | 13,375 | 101.20 | 1,353,496 |
2018-02-01 | Smith Barry M (Chief Executive Officer) | Sale | 13,375 | 99.20 | 1,326,759 |
2018-01-03 | Rubin Jonathan N (Chief Financial Officer) | Sale | 30,086 | 96.16 | 2,893,039 |
2018-01-02 | Rubin Jonathan N (Chief Financial Officer) | Sale | 17,443 | 96.07 | 1,675,783 |
2018-01-02 | Smith Barry M (Chief Executive Officer) | Sale | 13,367 | 95.94 | 1,282,429 |
2017-12-04 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 2,180 | 92.00 | 200,560 |
2017-12-04 | Lewis Clapper Caskie (Chief Human Resources Officer) | Sale | 59,313 | 93.99 | 5,574,591 |
2017-12-01 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 8,275 | 89.08 | 737,137 |
2017-11-02 | Rubin Jonathan N (Chief Financial Officer) | Option Ex | 2,420 | .00 | 0 |
2017-11-01 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 1,154 | 92.00 | 106,168 |
2017-11-01 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 9,369 | 89.20 | 835,752 |
2017-10-04 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 7,475 | 88.05 | 658,173 |
2017-10-03 | West Jeffrey N (SVP & Controller) | Sale | 30,021 | 87.31 | 2,621,253 |
2017-10-03 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 5,000 | 88.00 | 440,000 |
2017-10-02 | West Jeffrey N (SVP & Controller) | Sale | 19,007 | 86.22 | 1,638,688 |
2017-09-29 | West Jeffrey N (SVP & Controller) | Sale | 18,511 | 86.18 | 1,595,315 |
2017-09-28 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 4,848 | 85.76 | 415,783 |
2017-09-28 | West Jeffrey N (SVP & Controller) | Sale | 25,316 | 85.85 | 2,173,454 |
2017-09-27 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 19,126 | 85.68 | 1,638,753 |
2017-09-27 | West Jeffrey N (SVP & Controller) | Sale | 19,921 | 85.65 | 1,706,293 |
2017-09-27 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 35,658 | 85.17 | 3,036,920 |
2017-09-15 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 2,961 | 84.00 | 248,724 |
2017-09-15 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 2,402 | 83.00 | 199,366 |
2017-09-14 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 18,063 | 83.05 | 1,500,168 |
2017-09-13 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 585 | 83.00 | 48,555 |
2017-09-13 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 14,096 | 83.06 | 1,170,884 |
2017-09-12 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 19 | 83.00 | 1,577 |
2017-09-11 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 2,400 | 83.00 | 199,200 |
2017-09-08 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 6,267 | 81.53 | 510,917 |
2017-09-07 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 1,033 | 81.19 | 83,870 |
2017-09-05 | Kamal Mostafa (CEO, Magellan Rx Management) | Sale | 1,157 | 80.96 | 93,669 |
2017-07-25 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 4,559 | 80.68 | 367,820 |
2017-07-24 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 32,398 | 80.12 | 2,595,598 |
2017-07-21 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 1,176 | 80.02 | 94,102 |
2017-07-20 | West Jeffrey N (SVP & Controller) | Sale | 1,109 | 80.01 | 88,727 |
2017-07-20 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 16,073 | 80.06 | 1,286,756 |
2017-07-17 | West Jeffrey N (SVP & Controller) | Sale | 600 | 80.10 | 48,060 |
2017-07-14 | West Jeffrey N (SVP & Controller) | Sale | 27,914 | 80.06 | 2,234,934 |
2017-07-14 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 14,114 | 80.11 | 1,130,686 |
2017-03-05 | Kamal Mostafa (CEO, Magellan Rx Management) | Option Ex | 144 | .00 | 0 |
2017-03-05 | Srivastava Sanjeev K (CEO, Magellan Healthcare) | Option Ex | 1,338 | .00 | 0 |
2017-03-05 | Rubin Jonathan N (Chief Financial Officer) | Option Ex | 5,359 | .00 | 0 |
2017-03-05 | Lewis Clapper Caskie (Chief Human Resources Officer) | Option Ex | 2,656 | .00 | 0 |
2017-03-05 | West Jeffrey N (SVP & Controller) | Option Ex | 2,117 | .00 | 0 |
2017-03-05 | Gregoire Daniel N (General Counsel and Secretary) | Option Ex | 3,249 | .00 | 0 |
2017-03-04 | Kamal Mostafa (CEO, Magellan Rx Management) | Option Ex | 175 | .00 | 0 |
2017-03-04 | West Jeffrey N (SVP & Controller) | Option Ex | 615 | .00 | 0 |
2017-02-24 | West Jeffrey N (SVP & Controller) | Sale | 300 | 81.05 | 24,315 |
2017-02-24 | Smith Barry M (Chief Executive Officer) | Option Ex | 12,671 | .00 | 0 |
2017-02-23 | Broshy Eran (Director) | Sale | 4,867 | 80.00 | 389,360 |
2017-02-23 | West Jeffrey N (SVP & Controller) | Sale | 13,212 | 80.70 | 1,066,155 |
2017-02-03 | West Jeffrey N (SVP & Controller) | Sale | 15,055 | 76.46 | 1,151,105 |
2017-02-01 | West Jeffrey N (SVP & Controller) | Sale | 3,346 | 76.05 | 254,449 |
2016-12-08 | Lewis Clapper Caskie (Chief Human Resources Officer) | Sale | 39,593 | 74.67 | 2,956,488 |
2016-12-08 | Broshy Eran (Director) | Sale | 2,433 | 75.00 | 182,475 |
2016-12-07 | Rubin Jonathan N (Chief Financial Officer) | Sale | 29,953 | 73.36 | 2,197,501 |
2016-12-07 | Lewis Clapper Caskie (Chief Human Resources Officer) | Sale | 15,997 | 74.00 | 1,183,778 |
2016-12-06 | Rubin Jonathan N (Chief Financial Officer) | Sale | 13,013 | 73.05 | 950,573 |
2016-12-05 | Rubin Jonathan N (Chief Financial Officer) | Sale | 3,200 | 73.17 | 234,140 |
2016-12-01 | Rubin Jonathan N (Chief Financial Officer) | Sale | 1,150 | 73.25 | 84,237 |
2016-11-30 | Rubin Jonathan N (Chief Financial Officer) | Sale | 7,620 | 73.06 | 556,755 |
2016-11-29 | Rubin Jonathan N (Chief Financial Officer) | Sale | 7,177 | 73.04 | 524,236 |
2016-11-02 | Rubin Jonathan N (Chief Financial Officer) | Option Ex | 2,420 | .00 | 0 |
2016-07-12 | West Jeffrey N (SVP & Controller) | Buy | 267 | 51.99 | 13,881 |
2016-03-04 | West Jeffrey N (SVP & Controller) | Option Ex | 616 | .00 | 0 |
2016-01-15 | West Jeffrey N (SVP & Controller) | Buy | 105 | 52.41 | 5,503 |
2015-07-15 | West Jeffrey N (SVP & Controller) | Buy | 298 | 50.22 | 14,965 |
2015-06-23 | Rubin Jonathan N (Chief Financial Officer) | Sale | 324 | 73.00 | 23,652 |
2015-04-15 | Rubin Jonathan N (Chief Financial Officer) | Sale | 90 | 71.20 | 6,408 |
2015-03-30 | Blasi Tina (CEO, National Imaging Assoc.) | Sale | 10,527 | 70.02 | 737,079 |
2015-03-19 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 16,232 | 68.73 | 1,115,609 |
2015-03-18 | Lewis Clapper Caskie (Chief Human Resources Officer) | Sale | 29,998 | 68.00 | 2,039,864 |
2015-03-18 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 10,000 | 68.05 | 680,500 |
2015-03-16 | Rubin Jonathan N (Chief Financial Officer) | Sale | 21,270 | 66.59 | 1,416,433 |
2015-03-16 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 15,528 | 66.80 | 1,037,270 |
2015-03-13 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 8,622 | 66.22 | 570,905 |
2015-03-12 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 1,143 | 66.15 | 75,609 |
2015-03-05 | Field Robert W (CEO, Magellan Rx Management) | Option Ex | 995 | .00 | 0 |
2015-03-05 | Srivastava Sanjeev K (CEO, Magellan Healthcare) | Option Ex | 670 | .00 | 0 |
2015-03-05 | Rubin Jonathan N (Chief Financial Officer) | Option Ex | 5,695 | .00 | 0 |
2015-03-05 | Blasi Tina (CEO, NIA Magellan) | Option Ex | 4,006 | .00 | 0 |
2015-03-05 | Lewis Clapper Caskie (Chief Human Resources Officer) | Option Ex | 2,819 | .00 | 0 |
2015-03-05 | West Jeffrey N (General Counsel and Secretary) | Option Ex | 2,272 | .00 | 0 |
2015-03-05 | Gregoire Daniel N (General Counsel and Secretary) | Option Ex | 3,456 | .00 | 0 |
2015-03-02 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 20,365 | 64.48 | 1,313,175 |
2015-02-26 | Smith Barry M (Chief Executive Officer) | Option Ex | 10,137 | .00 | 0 |
2015-01-09 | West Jeffrey N (SVP & Controller) | Buy | 289 | 51.03 | 14,747 |
2014-09-04 | Blasi Tina (CEO, National Imaging Assoc.) | Option Ex | 333 | .00 | 0 |
2014-06-30 | Gregoire Daniel N (General Counsel and Secretary) | Sale | 21,675 | 62.25 | 1,349,247 |
2014-06-26 | Rubin Jonathan N (Chief Financial Officer) | Sale | 29,700 | 62.32 | 1,850,963 |
2014-06-25 | Rubin Jonathan N (Chief Financial Officer) | Sale | 18,400 | 62.58 | 1,151,380 |
2014-06-24 | Rubin Jonathan N (Chief Financial Officer) | Sale | 19,200 | 62.46 | 1,199,174 |
2014-06-23 | Rubin Jonathan N (Chief Financial Officer) | Sale | 21,700 | 62.73 | 1,361,219 |
2014-06-20 | Rubin Jonathan N (Chief Financial Officer) | Sale | 31,200 | 62.99 | 1,965,163 |
2014-06-19 | Rubin Jonathan N (Chief Financial Officer) | Sale | 18,600 | 62.73 | 1,166,722 |
2014-06-18 | Rubin Jonathan N (Chief Financial Officer) | Sale | 35,896 | 62.79 | 2,253,909 |
2014-06-17 | Rubin Jonathan N (Chief Financial Officer) | Sale | 23,996 | 62.22 | 1,493,055 |
2014-06-16 | Rubin Jonathan N (Chief Financial Officer) | Sale | 13,041 | 62.18 | 810,889 |
2014-06-16 | Blasi Tina (CEO, National Imaging Assoc.) | Sale | 10,775 | 62.07 | 668,815 |
2014-06-13 | Blasi Tina (CEO, National Imaging Assoc.) | Sale | 1,825 | 62.00 | 113,157 |
2014-06-12 | Blasi Tina (CEO, National Imaging Assoc.) | Sale | 8,422 | 62.04 | 522,484 |
2014-05-19 | Smith Barry M (Chief Executive Officer) | Buy | 10,000 | 58.56 | 585,630 |
2014-05-14 | Leblanc Robert M | Buy | 10,000 | 55.60 | 556,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of MGLN listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Magellan Health Inc (symbol MGLN,
CIK number 19411) see
the Securities and Exchange Commission (SEC) website.